Common Infections — MCQs
On this page
A hospital trust antimicrobial stewardship team analyses prescribing data and identifies that empirical antibiotic regimens for severe community-acquired pneumonia vary significantly between different medical teams, with some using co-amoxiclav and clarithromycin, others using co-amoxiclav and doxycycline, and some using dual beta-lactam combinations. Understanding the principles of antimicrobial stewardship, what is the primary reason why this variation in practice should be addressed?
A 61-year-old man with decompensated alcoholic liver cirrhosis (Child-Pugh C, MELD 28) presents with a 48-hour history of erythema, warmth, and swelling of his right lower leg without a defined entry point. He is haemodynamically stable. Blood tests show platelet count 45 × 10⁹/L, INR 2.1, and albumin 23 g/L. Which organism should empirical antibiotic therapy specifically cover in addition to the usual causes of cellulitis?
A 48-year-old woman with hidradenitis suppurativa presents with recurrent painful nodules and draining sinuses in her axillae and groin. She has failed multiple courses of antibiotics. Wound cultures have grown mixed flora including Staphylococcus aureus, Streptococcus milleri group, and anaerobes. According to current guidance, what is the most appropriate long-term antimicrobial management strategy?
A hospital antimicrobial stewardship committee reviews prescribing data showing that the average duration of antibiotic therapy for uncomplicated community-acquired pneumonia is 9.2 days, despite most patients being apyrexial and clinically stable by day 5. Which of the following quality improvement interventions would most effectively address this issue while maintaining patient safety?
A 73-year-old woman with breast cancer on chemotherapy develops neutropenic sepsis and is treated with piperacillin-tazobactam. On day 4, she develops a new painful erythematous rash on her thigh. The area is warm, swollen, and tender with a sharply demarcated raised border. Her neutrophil count has now recovered to 2.1 × 10⁹/L. Blood cultures from admission grew Escherichia coli sensitive to piperacillin-tazobactam. What is the most likely explanation for the new rash?
According to UK antimicrobial stewardship guidance, which of the following interventions has the strongest evidence base for reducing healthcare-associated Clostridioides difficile infection rates in hospital settings?
A 56-year-old man with poorly controlled type 2 diabetes (HbA1c 104 mmol/mol) presents with a 2-day history of severe perineal pain and swelling. On examination, he has scrotal oedema, crepitus on palpation, and foul-smelling discharge. His temperature is 38.9°C, heart rate 118 bpm, blood pressure 95/60 mmHg, and blood glucose 24.3 mmol/L. What is the most critical immediate intervention?
A 41-year-old man who recently underwent allogeneic stem cell transplantation for acute myeloid leukaemia presents with a painful ulcerated lesion on his left leg with surrounding cellulitis. He is currently on immunosuppression with ciclosporin and prednisolone. The lesion has a necrotic centre with violaceous borders. Skin biopsy shows vasculitis and tissue culture grows Pseudomonas aeruginosa. What is the most likely diagnosis?
A hospital implements a new antimicrobial stewardship intervention requiring all patients started on restricted antimicrobials to have documented microbiology review within 48 hours. After 6 months, audit data shows 85% compliance with this target. However, overall antimicrobial consumption measured in defined daily doses (DDDs) has not changed significantly. Which aspect of the intervention most likely explains this observation?
A 67-year-old woman with chronic lymphocytic leukaemia on ibrutinib presents with a 4-day history of facial cellulitis. She has a documented penicillin allergy (anaphylaxis). Blood cultures grow Gram-positive cocci in clusters. She has been receiving intravenous vancomycin but after 72 hours shows minimal clinical improvement. Her renal function is normal. What is the most appropriate next step in her antimicrobial management?
Common Infections UK Medical PG Practice Questions and MCQs
Question 31: A hospital trust antimicrobial stewardship team analyses prescribing data and identifies that empirical antibiotic regimens for severe community-acquired pneumonia vary significantly between different medical teams, with some using co-amoxiclav and clarithromycin, others using co-amoxiclav and doxycycline, and some using dual beta-lactam combinations. Understanding the principles of antimicrobial stewardship, what is the primary reason why this variation in practice should be addressed?
- A. Variation increases the risk of prescribing errors and reduces reliability of care delivery (Correct Answer)
- B. Some regimens are more expensive than others, impacting healthcare costs unnecessarily
- C. Dual beta-lactam combinations provide no additional microbiological coverage
- D. This variation makes audit and monitoring of antimicrobial prescribing more difficult
- E. Different regimens have different adverse effect profiles affecting patient safety
Explanation: ***Variation increases the risk of prescribing errors and reduces reliability of care delivery***- Standardizing care pathways according to **antimicrobial stewardship** principles minimizes **cognitive load** for clinicians, which reduces the likelihood of dosing or drug-selection errors.- Consistent application of **evidence-based guidelines** ensures a predictable, high-quality standard of care for all patients, regardless of which medical team is managing them.*Some regimens are more expensive than others, impacting healthcare costs unnecessarily*- While **cost-effectiveness** is a pillar of healthcare management, antimicrobial stewardship prioritizes **clinical outcomes** and the prevention of **resistance** over simple budgetary savings.- Economic considerations are a secondary benefit of standardization rather than the primary driver for clinical safety initiatives.*Dual beta-lactam combinations provide no additional microbiological coverage*- Using two **beta-lactams** simultaneously is clinically irrational due to overlapping mechanisms, but this is a specific clinical error rather than the systemic reason for addressing overall **practice variation**.- Addressing this specific regimen only fixes one localized issue instead of improving the **reliability of the prescribing system** as a whole.*This variation makes audit and monitoring of antimicrobial prescribing more difficult*- While non-standardized practice complicates **clinical audits** and data collection, this is an administrative hurdle rather than a direct threat to **patient safety**.- The goal of stewardship is to improve patient care; easier data monitoring is a functional outcome of standardization, not its primary objective.*Different regimens have different adverse effect profiles affecting patient safety*- All antibiotics carry risks of **side effects** (e.g., C. difficile, toxicity), but the primary stewardship concern with variation is the **lack of a systematic approach** to managing these risks.- The variability itself creates a higher risk of **unforeseen drug interactions** and monitoring failures compared to a single, well-known trust guideline.
Question 32: A 61-year-old man with decompensated alcoholic liver cirrhosis (Child-Pugh C, MELD 28) presents with a 48-hour history of erythema, warmth, and swelling of his right lower leg without a defined entry point. He is haemodynamically stable. Blood tests show platelet count 45 × 10⁹/L, INR 2.1, and albumin 23 g/L. Which organism should empirical antibiotic therapy specifically cover in addition to the usual causes of cellulitis?
- A. Vibrio vulnificus (Correct Answer)
- B. Aeromonas hydrophila
- C. Listeria monocytogenes
- D. Cryptococcus neoformans
- E. Capnocytophaga canimorsus
Explanation: ***Vibrio vulnificus*** - Patients with **decompensated cirrhosis**, particularly with underlying **iron overload**, are at extremely high risk for rapidly progressive and fatal infections from **Vibrio vulnificus**. - This organism commonly causes **fulminant cellulitis** (often with **hemorrhagic bullae**), primary **sepsis**, and can occur spontaneously or after seafood/saltwater exposure. *Aeromonas hydrophila* - While **Aeromonas** can cause serious skin and soft tissue infections, especially in immunocompromised individuals or those with **freshwater exposure**, it is not the primary organism of concern for spontaneous, rapidly progressive cellulitis in a cirrhotic patient without clear aquatic exposure, as compared to **Vibrio**. - It can cause similar symptoms but is less specifically associated with the high mortality and rapid progression seen in cirrhotic patients with **Vibrio vulnificus** infections. *Listeria monocytogenes* - **Listeria** is primarily known for causing **meningitis** and **sepsis** in vulnerable populations like the elderly, neonates, pregnant women, and other immunocompromised individuals (e.g., solid organ transplant recipients). - It is not a typical pathogen for **cellulitis** or spontaneous soft tissue infections in the context of alcoholic liver cirrhosis. *Cryptococcus neoformans* - **Cryptococcus** is an **opportunistic fungus** that primarily affects individuals with severe T-cell mediated immunodeficiency, most notably those with advanced **HIV/AIDS** or recipients of solid organ transplants on immunosuppressants. - It typically causes **meningitis** or pulmonary infections; cutaneous manifestations are usually papules or nodules and not an acute, rapidly spreading **cellulitis**. *Capnocytophaga canimorsus* - **Capnocytophaga canimorsus** is typically associated with severe infections, including sepsis and cellulitis, following **dog or cat bites/scratches**, especially in individuals with **asplenia** or chronic liver disease. - The patient's presentation of spontaneous cellulitis without a history of animal contact makes this organism a less likely primary target for empirical therapy in this specific scenario.
Question 33: A 48-year-old woman with hidradenitis suppurativa presents with recurrent painful nodules and draining sinuses in her axillae and groin. She has failed multiple courses of antibiotics. Wound cultures have grown mixed flora including Staphylococcus aureus, Streptococcus milleri group, and anaerobes. According to current guidance, what is the most appropriate long-term antimicrobial management strategy?
- A. Long-term oral clindamycin 300mg twice daily for 12 weeks combined with rifampicin 300mg twice daily for 12 weeks (Correct Answer)
- B. Long-term oral doxycycline 100mg twice daily as suppressive therapy
- C. Rotating courses of different antibiotics every 2-4 weeks to prevent resistance
- D. Intravenous ertapenem 1g daily for 6 weeks
- E. No antimicrobial therapy; focus on surgical management and biologics
Explanation: ***Long-term oral clindamycin 300mg twice daily for 12 weeks combined with rifampicin 300mg twice daily for 12 weeks*** - This **combination therapy** with **clindamycin and rifampicin** is a first-line systemic treatment for moderate to severe **Hidradenitis Suppurativa (HS)**, especially when initial antibiotic courses have failed. - **Clindamycin** targets gram-positive bacteria like *Staphylococcus aureus* and **anaerobes**, while **rifampicin** reduces **biofilm formation** and synergizes with clindamycin, effectively managing the deep-seated infections characteristic of this condition. *Long-term oral doxycycline 100mg twice daily as suppressive therapy* - **Tetracyclines** like doxycycline are primarily used for **mild Hidradenitis Suppurativa (Hurley stage I)** due to their anti-inflammatory properties. - The patient's presentation with **recurrent painful nodules** and **draining sinuses** indicates more advanced disease that requires a more potent and comprehensive antimicrobial approach. *Rotating courses of different antibiotics every 2-4 weeks to prevent resistance* - This strategy is **not evidence-based** for hidradenitis suppurativa and does not align with current treatment guidelines. - **Frequent antibiotic rotation** can actually contribute to the development of **antimicrobial resistance** and does not provide the sustained therapeutic levels needed for deep-seated infections in HS. *Intravenous ertapenem 1g daily for 6 weeks* - **Intravenous ertapenem** is a broad-spectrum antibiotic generally reserved for **severe, refractory cases** of HS or acute flares, often as a short-term "rescue" therapy. - It is not considered a standard **long-term management strategy** due to its intravenous administration, which poses significant logistical challenges and risks for prolonged outpatient use. *No antimicrobial therapy; focus on surgical management and biologics* - While **surgical management** and **biologic therapies** (e.g., adalimumab) are crucial for moderate to severe HS, they are often used *in conjunction with* antimicrobials. - Given the **mixed flora** and active inflammatory components, entirely omitting antimicrobial therapy would neglect the infectious burden and could hinder overall disease control.
Question 34: A hospital antimicrobial stewardship committee reviews prescribing data showing that the average duration of antibiotic therapy for uncomplicated community-acquired pneumonia is 9.2 days, despite most patients being apyrexial and clinically stable by day 5. Which of the following quality improvement interventions would most effectively address this issue while maintaining patient safety?
- A. Implement automatic stop orders for all pneumonia prescriptions at 5 days unless renewed
- B. Develop and implement a clinical decision support tool with evidence-based stop/review dates at time of prescribing (Correct Answer)
- C. Conduct educational sessions for junior doctors on guideline-recommended durations
- D. Require consultant approval for all antibiotic prescriptions beyond 5 days
- E. Send weekly emails to all prescribers highlighting the audit findings and guidelines
Explanation: ***Develop and implement a clinical decision support tool with evidence-based stop/review dates at time of prescribing*** - This approach integrates **evidence-based guidelines** directly into the prescribing workflow, making the correct behavior the **default easy option** and promoting adherence. - It allows for **proactive planning** of antibiotic duration based on clinical context while still permitting overrides for individual patient needs, thus maintaining safety. *Implement automatic stop orders for all pneumonia prescriptions at 5 days unless renewed* - **Hard stops** without integrated clinical decision support can potentially compromise **patient safety** if a patient genuinely requires a longer course and the order is inadvertently terminated. - This method shifts the responsibility to reactively re-prescribe rather than encouraging **proactive, evidence-based duration planning** at the initial prescribing stage. *Conduct educational sessions for junior doctors on guideline-recommended durations* - While beneficial for knowledge, **educational interventions** alone are generally considered "low-reliability" strategies for sustained behavioral change and often have limited impact on prescribing habits. - They do not address **systemic barriers** or provide immediate, in-workflow guidance at the point of prescribing, where decisions are made. *Require consultant approval for all antibiotic prescriptions beyond 5 days* - This creates a **significant bureaucratic burden** on consultants and may lead to delays in necessary therapy or contribute to **physician burnout** due to increased workload. - It is a highly **resource-intensive** measure that focuses on oversight and restriction rather than empowering prescribers with tools for better decision-making. *Send weekly emails to all prescribers highlighting the audit findings and guidelines* - **Passive interventions** like mass emails are often subject to "information overload" and have been shown to have very **low effectiveness** in consistently changing established clinical habits. - **Audit and feedback** are more impactful when delivered in a personalized manner and integrated directly into the **clinical workflow** rather than through generic, non-interactive communication.
Question 35: A 73-year-old woman with breast cancer on chemotherapy develops neutropenic sepsis and is treated with piperacillin-tazobactam. On day 4, she develops a new painful erythematous rash on her thigh. The area is warm, swollen, and tender with a sharply demarcated raised border. Her neutrophil count has now recovered to 2.1 × 10⁹/L. Blood cultures from admission grew Escherichia coli sensitive to piperacillin-tazobactam. What is the most likely explanation for the new rash?
- A. Immune reconstitution inflammatory syndrome as neutrophils recover (Correct Answer)
- B. Breakthrough infection with a resistant organism
- C. Allergic reaction to piperacillin-tazobactam
- D. Cellulitis caused by a separate bacterial infection
- E. Cutaneous manifestation of underlying malignancy
Explanation: ***Immune reconstitution inflammatory syndrome as neutrophils recover*** - The inflammatory response was initially absent during the **neutropenic** phase; as the **neutrophil count** recovers to 2.1 × 10⁹/L, the body mounts a sudden response against bacteria (like the *E. coli* found in blood) that had seeded into tissues. - This leads to the appearance of a **new, painful, erythematous rash** with a raised border, mimicking a worsening infection despite effective antibiotic treatment. *Breakthrough infection with a resistant organism* - The admission blood cultures grew *E. coli* which was **sensitive** to the current regimen of **piperacillin-tazobactam**, making resistance unlikely. - A breakthrough infection typically results in clinical deterioration rather than localized inflammation coinciding exactly with **neutrophil recovery**. *Allergic reaction to piperacillin-tazobactam* - Drug allergies usually present as a **diffuse maculopapular rash** or urticaria rather than a localized, sharply demarcated, warm, and swollen area on one thigh. - An allergic reaction would not typically correspond with the specific timing of **bone marrow recovery**. *Cellulitis caused by a separate bacterial infection* - While localized inflammation resembles **cellulitis**, the rapid onset coinciding with recovery of the **neutrophil count** suggests an inflammatory rebound rather than a de novo infection. - Standard cellulitis would be unlikely to develop while the patient is already receiving broad-spectrum **antipseudomonal** coverage (piperacillin-tazobactam). *Cutaneous manifestation of underlying malignancy* - Paraneoplastic syndromes usually present with chronic, progressive, or recurring morphological patterns rather than an **acute inflammatory** rash during sepsis treatment. - The timing and clinical history of **neutropenic sepsis** point towards an infectious or immune-mediated etiology rather than a direct effect of **breast cancer**.
Question 36: According to UK antimicrobial stewardship guidance, which of the following interventions has the strongest evidence base for reducing healthcare-associated Clostridioides difficile infection rates in hospital settings?
- A. Implementing antimicrobial formulary restrictions for fluoroquinolones and cephalosporins (Correct Answer)
- B. Mandatory hand hygiene audits with alcohol-based hand rub on all clinical areas
- C. Universal screening of all hospital admissions for Clostridioides difficile carriage
- D. Routine prophylactic administration of probiotics to patients receiving antibiotics
- E. Weekly environmental cleaning audits with ATP bioluminescence monitoring
Explanation: ***Implementing antimicrobial formulary restrictions for fluoroquinolones and cephalosporins*** - Restricting high-risk antibiotics, particularly **fluoroquinolones**, **cephalosporins**, and clindamycin, is the most robust evidence-based strategy for reducing **healthcare-associated CDI** rates. - Clinical evidence and UK national stewardship initiatives have demonstrated that such **formulary interventions** directly correlate with a significant decline in *C. difficile* incidence. *Mandatory hand hygiene audits with alcohol-based hand rub on all clinical areas* - **Alcohol-based hand rubs** are ineffective against **Clostridioides difficile spores**, which are resistant to alcohol-mediated denaturation. - Effective hand hygiene for *C. difficile* requires physical removal of spores using **soap and water** washing rather than just alcohol-based sanitization. *Universal screening of all hospital admissions for Clostridioides difficile carriage* - Universal screening is not currently recommended as it is not **cost-effective** and many patients carry the bacteria without progressing to **active disease**. - Primary management focuses on **symptomatic patients** and reducing the selective pressure of antibiotics rather than identifying asymptomatic carriers. *Routine prophylactic administration of probiotics to patients receiving antibiotics* - Evidence for **probiotic prophylaxis** is inconsistent and lacks the strong clinical weighting required for universal UK antimicrobial stewardship recommendations. - There are significant safety concerns regarding the use of probiotics in **immunocompromised patients**, where they may lead to **fungemia** or bacteremia. *Weekly environmental cleaning audits with ATP bioluminescence monitoring* - While **environmental decontamination** with sporicidal agents is essential, cleaning audits alone have a weaker direct evidence base for reducing infection rates than **antimicrobial stewardship**. - ATP bioluminescence measures general **organic material** but does not specifically confirm the elimination of hardy **C. difficile spores**.
Question 37: A 56-year-old man with poorly controlled type 2 diabetes (HbA1c 104 mmol/mol) presents with a 2-day history of severe perineal pain and swelling. On examination, he has scrotal oedema, crepitus on palpation, and foul-smelling discharge. His temperature is 38.9°C, heart rate 118 bpm, blood pressure 95/60 mmHg, and blood glucose 24.3 mmol/L. What is the most critical immediate intervention?
- A. Commence broad-spectrum intravenous antibiotics including anaerobic cover
- B. Obtain urgent surgical review for debridement (Correct Answer)
- C. Commence insulin infusion to control hyperglycaemia
- D. Fluid resuscitation with crystalloid and vasopressor support
- E. Obtain urgent CT scan of pelvis and perineum to delineate extent of infection
Explanation: ***Obtain urgent surgical review for debridement***- This patient has **Fournier's gangrene**, a necrotizing fasciitis of the perineum; **urgent surgical debridement** is the definitive treatment to stop disease progression and reduce high mortality rates.- Clinical signs like **crepitus**, foul-smelling discharge, and rapid systemic decline make this a clinical diagnosis where **source control** takes absolute precedence over all other interventions.*Commence broad-spectrum intravenous antibiotics including anaerobic cover*- While **early antibiotics** are essential to manage polymicrobial infection, they cannot penetrate the **necrotic tissue** and are insufficient without surgical removal of the infected focus.- Antibiotic therapy is an **adjunctive measure** and should be started immediately, but it does not replace the need for an emergent surgical consultation.*Commence insulin infusion to control hyperglycaemia*- Managing **hyperglycemia** and metabolic derangements (HbA1c 104 mmol/mol) is important for wound healing and immune function, but it is a **supportive intervention** rather than a life-saving one in this acute setting.- Metabolic stabilization should occur **concurrently** with surgical preparation but should never delay the trip to the operating room.*Fluid resuscitation with crystalloid and vasopressor support*- Aggressive **fluid resuscitation** is vital for managing **septic shock** (hypotension and tachycardia), but it is supportive and will fail without addressing the underlying source of sepsis.- Hemodynamic stabilization should be initiated in the **pre-operative phase** while the surgical team is being mobilized.*Obtain urgent CT scan of pelvis and perineum to delineate extent of infection*- Imaging such as a **CT scan** can help determine the extent of gas and tissue involvement, but it should **never delay surgery** when the diagnosis is clear clinically.- In a patient with **crepitus and systemic shock**, a macroscopic diagnosis is sufficient, and the priority is avoid time-to-debridement delays.
Question 38: A 41-year-old man who recently underwent allogeneic stem cell transplantation for acute myeloid leukaemia presents with a painful ulcerated lesion on his left leg with surrounding cellulitis. He is currently on immunosuppression with ciclosporin and prednisolone. The lesion has a necrotic centre with violaceous borders. Skin biopsy shows vasculitis and tissue culture grows Pseudomonas aeruginosa. What is the most likely diagnosis?
- A. Ecthyma gangrenosum (Correct Answer)
- B. Pyoderma gangrenosum
- C. Necrotising fasciitis
- D. Cutaneous mucormycosis
- E. Sweet's syndrome
Explanation: ***Ecthyma gangrenosum***- This is a classic cutaneous sign of **Pseudomonas aeruginosa** bacteremia, typically occurring in **immunocompromised** patients such as stem cell transplant recipients.- The characteristic lesion features a **necrotic center** (black eschar) with a **violaceous border**, caused by bacterial invasion of blood vessels leading to **perivascular vasculitis**.*Pyoderma gangrenosum*- Although it presents as a painful ulcer with violaceous edges, it is a **sterile neutrophilic dermatosis** and would not grow Pseudomonas on culture.- It is frequently associated with **inflammatory bowel disease** or hematologic malignancies but does not involve infectious vasculitis.*Necrotising fasciitis*- This typically presents as a rapidly spreading infection of the **deep fascia** with severe systemic toxicity and **dishwater discharge**.- While it can be caused by various bacteria, it lacks the specific **ecthyma-like eschar** and localized vascular invasion characteristic of Pseudomonas.*Cutaneous mucormycosis*- This fungal infection also causes necrotic lesions in immunocompromised hosts, but tissue culture would reveal **broad, non-septate hyphae**.- It does not grow **Pseudomonas aeruginosa**, which is the specific causative agent identified in this clinical scenario.*Sweet's syndrome*- Also known as **acute febrile neutrophilic dermatosis**, it presents with tender, erythematous plaques or nodules rather than necrotic ulcers.- Histology shows a dense **neutrophilic infiltrate** in the dermis without the presence of bacteria or true vasculitis.
Question 39: A hospital implements a new antimicrobial stewardship intervention requiring all patients started on restricted antimicrobials to have documented microbiology review within 48 hours. After 6 months, audit data shows 85% compliance with this target. However, overall antimicrobial consumption measured in defined daily doses (DDDs) has not changed significantly. Which aspect of the intervention most likely explains this observation?
- A. The intervention focused on process measures rather than outcome measures that directly impact prescribing behaviour (Correct Answer)
- B. Microbiology review at 48 hours is too early to influence antimicrobial de-escalation decisions
- C. The defined daily dose methodology is inappropriate for measuring antimicrobial consumption in hospital settings
- D. Restricted antimicrobials represent too small a proportion of total antimicrobial use to affect overall consumption
- E. Compliance of 85% is insufficient to achieve measurable changes in antimicrobial consumption patterns
Explanation: ***The intervention focused on process measures rather than outcome measures that directly impact prescribing behaviour*** - High compliance with a **process measure** (documenting a review) does not guarantee a change in clinical practice or **prescribing behaviour**. - For an intervention to reduce **Defined Daily Doses (DDDs)**, it must actively lead to **de-escalation**, discontinuation, or optimization of therapy, not just documentation. *Microbiology review at 48 hours is too early to influence antimicrobial de-escalation decisions* - A **48-hour review** is standard practice because it typically coincides with the availability of **preliminary culture results** and sensitivity data. - This timeframe is considered the "antibiotic time-out," where clinicians have enough information to switch from **empiric to directed therapy**. *The defined daily dose methodology is inappropriate for measuring antimicrobial consumption in hospital settings* - **DDDs** are the **WHO-standardized** unit for monitoring antimicrobial consumption and comparing usage data across different settings. - While it has limitations in children or patients with renal failure, it is a robust and widely accepted **outcome measure** for hospital-wide stewardship. *Restricted antimicrobials represent too small a proportion of total antimicrobial use to affect overall consumption* - **Restricted antimicrobials** are often broad-spectrum agents that contribute significantly to the total **DDD count** and selection pressure for resistance. - Managing these high-priority drugs is a core component of **antimicrobial stewardship** and should theoretically impact consumption metrics if done effectively. *Compliance of 85% is insufficient to achieve measurable changes in antimicrobial consumption patterns* - An **85% compliance rate** is generally considered high in quality improvement audits and should be sufficient to demonstrate a trend if the intervention was effective. - The lack of impact on **DDDs** despite high compliance suggests the weakness lies in the **intervention design** (the nature of the review), not the level of adherence.
Question 40: A 67-year-old woman with chronic lymphocytic leukaemia on ibrutinib presents with a 4-day history of facial cellulitis. She has a documented penicillin allergy (anaphylaxis). Blood cultures grow Gram-positive cocci in clusters. She has been receiving intravenous vancomycin but after 72 hours shows minimal clinical improvement. Her renal function is normal. What is the most appropriate next step in her antimicrobial management?
- A. Request vancomycin trough levels and adjust dosing accordingly (Correct Answer)
- B. Switch to intravenous linezolid 600mg twice daily
- C. Add intravenous rifampicin to the vancomycin regimen
- D. Switch to intravenous daptomycin 6mg/kg once daily
- E. Switch to intravenous teicoplanin with loading doses
Explanation: ***Request vancomycin trough levels and adjust dosing accordingly*** - Success with **vancomycin** therapy is highly dependent on achieving therapeutic **trough levels** (typically 15-20 mg/L for serious Gram-positive infections like bacteremia or cellulitis with systemic signs); subtherapeutic levels are a primary cause of apparent treatment failure. - Before escalating to alternative antibiotics or concluding vancomycin failure, **therapeutic drug monitoring (TDM)** is crucial to ensure optimal dosing, especially since the patient has **normal renal function**, allowing for safe dose adjustments. *Switch to intravenous linezolid 600mg twice daily* - **Linezolid** is typically reserved for confirmed **vancomycin-resistant** Gram-positive infections (e.g., VRE, VRSA) or in cases of severe vancomycin intolerance, not merely for slow clinical response without documented subtherapeutic levels. - As a **bacteriostatic** agent against staphylococci, it might be less effective than an optimized vancomycin regimen in severe infections if the initial vancomycin dose was inadequate. *Add intravenous rifampicin to the vancomycin regimen* - Adding **rifampicin** is primarily considered for **staphylococcal infections** involving **prosthetic material** (e.g., joint prostheses, heart valves, vascular grafts) due to its activity against **biofilms**. Simple cellulitis without foreign bodies does not typically warrant its addition. - Rifampicin is a potent **CYP450 inducer**, leading to numerous **drug interactions**, and can cause **hepatotoxicity**, making its use in simple cellulitis without a clear indication generally avoided. *Switch to intravenous daptomycin 6mg/kg once daily* - **Daptomycin** is a potent bactericidal agent against Gram-positive bacteria, including **MRSA**, and is an appropriate alternative for complicated skin and soft tissue infections. However, like linezolid, it should be considered after confirming **vancomycin failure** or contraindication. - Switching before optimizing vancomycin risks premature use of a valuable agent, potentially contributing to **resistance development** and incurring higher costs, especially when vancomycin efficacy hasn't been fully explored. *Switch to intravenous teicoplanin with loading doses* - **Teicoplanin** is another glycopeptide antibiotic with a similar mechanism of action and spectrum to vancomycin. Simply switching to teicoplanin without addressing the potential issue of **inadequate vancomycin levels** is unlikely to resolve the treatment failure. - While an alternative for penicillin-allergic patients or those intolerant to vancomycin, its primary role here would be if vancomycin itself was deemed ineffective despite appropriate levels, or if there was a vancomycin-specific adverse effect.
Practice by Chapter
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free